211 related articles for article (PubMed ID: 15385800)
1. Active role of chimerism in transplantation tolerance induced by antilymphocyte serum, sirolimus, and bone-marrow-cell infusion.
Kanamoto A; Monaco AP; Maki T
Transplantation; 2004 Sep; 78(6):825-30. PubMed ID: 15385800
[TBL] [Abstract][Full Text] [Related]
2. Chimeric donor cells play an active role in both induction and maintenance phases of transplantation tolerance induced by mixed chimerism.
Kanamoto A; Maki T
J Immunol; 2004 Feb; 172(3):1444-8. PubMed ID: 14734720
[TBL] [Abstract][Full Text] [Related]
3. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
Fukuzaki T; Hancock WW; Monaco AP; Maki T
Transplantation; 1998 Apr; 65(8):1036-43. PubMed ID: 9583862
[TBL] [Abstract][Full Text] [Related]
4. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
Hale DA; Gottschalk R; Maki T; Monaco AP
Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
[TBL] [Abstract][Full Text] [Related]
5. Donor T cells are not required for induction of allograft tolerance in mice treated with antilymphocyte serum, rapamycin, and donor bone marrow cells.
Umemura A; Monaco AP; Maki T
Transplantation; 2000 Oct; 70(7):1005-9. PubMed ID: 11045634
[TBL] [Abstract][Full Text] [Related]
6. Immunologic mechanisms in tolerance produced in mice with nonradiation-based lymphoablation and donor-specific bone marrow.
Hale DA; Gottschalk R; Umemura A; Maki T; Monaco AP
Transplantation; 2002 Aug; 74(4):477-84. PubMed ID: 12352905
[TBL] [Abstract][Full Text] [Related]
7. Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow.
Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
Transplantation; 1997 Feb; 63(3):359-64. PubMed ID: 9039923
[TBL] [Abstract][Full Text] [Related]
8. Late adjunctive therapy with single doses of rapamycin in skin-allografted mice treated with antilymphocyte serum and donor bone marrow cells.
De Fazio SR; Plowey JM; Hartner WC; Gozzo JJ
Transpl Immunol; 1996 Jun; 4(2):105-12. PubMed ID: 8843586
[TBL] [Abstract][Full Text] [Related]
9. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
Dono K; Maki T; Wood ML; Monaco AP
Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
[TBL] [Abstract][Full Text] [Related]
10. Targeted T-cell depletion or CD154 blockade generates mixed hemopoietic chimerism and donor-specific tolerance in mice treated with sirolimus and donor bone marrow.
Anam K; Akpinar E; Craighead N; Black AT; Hale DA
Transplantation; 2004 Nov; 78(9):1290-8. PubMed ID: 15548965
[TBL] [Abstract][Full Text] [Related]
11. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice.
Ohzato H; Monaco AP
Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774
[TBL] [Abstract][Full Text] [Related]
12. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
Tomita Y; Sachs DH; Khan A; Sykes M
Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
[TBL] [Abstract][Full Text] [Related]
13. A clinically relevant CTLA4-Ig-based regimen induces chimerism and tolerance to heart grafts.
Li S; Thanikachalam M; Pang M; Kawaharada N; Aitouche A; Pham SM
Ann Thorac Surg; 2001 Oct; 72(4):1306-10. PubMed ID: 11603451
[TBL] [Abstract][Full Text] [Related]
14. Establishment of stable multilineage hematopoietic chimerism and donor-specific tolerance without irradiation.
Hale DA; Gottschalk R; Umemura A; Maki T; Monaco AP
Transplantation; 2000 Apr; 69(7):1242-51. PubMed ID: 10798737
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival of cardiac xenografts in fully xenogeneic (mouse --> rat) bone marrow chimeras.
Mohiuddin MM; Qin Y; Qian X; Meng Y; DiSesa VJ
Ann Thorac Surg; 2001 Sep; 72(3):740-5; discussion 745-6. PubMed ID: 11565651
[TBL] [Abstract][Full Text] [Related]
16. Chimeric acceleration by donor CD4+CD25+T-reg depleted fraction in splenocyte transplantation.
Kutsuna N; Yamazaki S; Kaiga T; Inagaki Y; Hayashi Y; Kanamoto A; Okada S; Takayama T
J Surg Res; 2012 Nov; 178(1):133-8. PubMed ID: 22502904
[TBL] [Abstract][Full Text] [Related]
17. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
Ildstad ST; Wren SM; Oh E; Hronakes ML
Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
[TBL] [Abstract][Full Text] [Related]
18. Targeted bone marrow radioablation with 153Samarium-lexidronam promotes allogeneic hematopoietic chimerism and donor-specific immunologic hyporesponsiveness.
Inverardi L; Linetsky E; Pileggi A; Molano RD; Serafini A; Paganelli G; Ricordi C
Transplantation; 2004 Mar; 77(5):647-55. PubMed ID: 15021823
[TBL] [Abstract][Full Text] [Related]
19. Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide.
Tomita Y; Yoshikawa M; Zhang QW; Shimizu I; Okano S; Iwai T; Yasui H; Nomoto K
J Immunol; 2000 Jul; 165(1):34-41. PubMed ID: 10861032
[TBL] [Abstract][Full Text] [Related]
20. Potent skin allograft survival prolongation using a committed progenitor fraction of bone marrow in mice.
Akpinar E; Craighead N; Smoot D; Hale DA
Transplantation; 2004 Aug; 78(3):383-91. PubMed ID: 15316366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
